Kevin Gorman
Förmögenhet: 80 M $ per 2026-08-31
Förmögenhet: 80 M $ per 2026-08-31
Kevin Charles Gorman is the founder of Neurocrine Biosciences, Inc., founded in 1992, where the title held is Independent Director starting in 2024.
Dr. Gorman currently serves as an Independent Director at Xencor, Inc. since 2017.
Formerly, Dr. Gorman was Principal at Avalon Medical Partners LP from 1990 to 1993.
Education includes an MBA and a doctorate from the University of California, Los Angeles.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-09-11 | 517 797 ( 0,51 % ) | 80 M $ | 2026-08-31 | |
XENCOR, INC. 0,03 % | 2026-06-16 | 21 680 ( 0,03 % ) | 591 105 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Grundare | 1992-01-01 |
| XENCOR, INC. | Direktör/Styrelseledamot | 2017-04-14 |
| Företag | Position | Slut |
|---|---|---|
Avalon Medical Partners LP | Företagsledare/Principal | 1993-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Xencor, Inc.
Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalon Medical Partners LP |
Välj din utgåva
All finansiell information anpassad till den nationella nivån